Aurora Cannabis (TSE:ACB – Get Free Report) was upgraded by equities research analysts at TD Securities to a “strong-buy” rating in a research report issued to clients and investors on Thursday,Zacks.com reports.
Aurora Cannabis Stock Performance
Shares of ACB stock opened at C$6.15 on Thursday. The firm has a market capitalization of C$336.16 million, a price-to-earnings ratio of -9.76 and a beta of 2.71. The company has a debt-to-equity ratio of 16.95, a current ratio of 3.76 and a quick ratio of 2.48. The business has a fifty day moving average of C$6.96 and a 200 day moving average of C$7.61. Aurora Cannabis has a 1 year low of C$3.84 and a 1 year high of C$12.85.
Insider Buying and Selling
In other Aurora Cannabis news, Senior Officer Andre Jerome sold 7,712 shares of the stock in a transaction dated Monday, September 23rd. The stock was sold at an average price of C$7.70, for a total transaction of C$59,382.40.
About Aurora Cannabis
Aurora Cannabis Inc, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally. It operates through two segments, Canadian Cannabis and Plant Propagation. The company offers medical and consumer cannabis products; supplies propagated vegetables and ornamental plants; and distributes and sells hemp-derived cannabidiol (CBD) products.
Featured Articles
- Five stocks we like better than Aurora Cannabis
- 3 Best Fintech Stocks for a Portfolio Boost
- FinWise Bancorp’s CEO Talks Strategy Behind Fintech Success
- The Role Economic Reports Play in a Successful Investment Strategy
- Broadcom: Turning the Mag 7 Into 8 Trillion-Dollar Tech Giants
- What is the NASDAQ Stock Exchange?
- SoundHound AI: Can Its Meteoric Rise Sustain Into 2025?
Receive News & Ratings for Aurora Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurora Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.